U.S., May 31 -- ClinicalTrials.gov registry received information related to the study (NCT06996184) titled 'Effect of Food on the Oral Bioavailability of a Prolonged-release Formulation of Vamifeport in Healthy Adults' on May 21.
Brief Summary: This is a phase I, single-center, randomized, open-label, single-dose, 2-way, 2-period, crossover study to evaluate the effect of food on the pharmacokinetics (PK) of vamifeport prolonged-release (PR) formulation in healthy adult participants. Participants will be randomly allocated to one of two treatment sequences.
Study Start Date: June 30
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: Vamifeport (PR formulation)
Vamifeport will be administered orally
Recruit...